Technetium complexes of a hydrazinonicotinamide-conjugated cyclic peptide and 2-hydrazinopyridine: Synthesis and characterization

被引:52
作者
Liu, S [1 ]
Edwards, DS [1 ]
Harris, AR [1 ]
Heminway, SJ [1 ]
Barrett, JA [1 ]
机构
[1] Dupont Merck Pharmaceut Co, Med Imaging Div, N Billerica, MA 01862 USA
关键词
D O I
10.1021/ic980973o
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Ternary ligand technetium complexes of a hydrazinonicotinamide-conjugated cyclic peptide (HYNICtide: cyclo(D-Val-NMeArg-Gly-Asp-Mamb(5-(6-(6-hydrazinonicotinamido)hexanamide)))) and 2-hydrazinopyridine (HYPY) were prepared and characterized by various spectroscopic methods. The HPLC concordance experiments for Tc-99m and Tc-99 analogues show clearly that the same complexes are prepared on the no-carrier-added (Tc-99m) and the carrier-added (Tc-99) levels. Using a chirality experiment, it was demonstrated that the presence of two radiometric peaks in the HPLC chromatograms of RP444, RP445, and RP446 is due to the resolution of diastereomers, which result: from the presence of chiral cyclic peptide and the formation of two enantiomers of the technetium chelate. In a ligand challenge experiment, we found that the high solution stability of these ternary ligand [Tc-99m]HYNICtide complexes is due to their kinetic inertness. The 1:1:1:1 composition for Tc:HYNICtide:L:tricine (L = TPPTS, TPPDS, and TPPMS) in these ternary ligand [Tc-99]HYNICtide complexes is confirmed by H-1 NMR and FAB mass spectral data and is completely consistent: with that determined on the tracer (Tc-99m) level. In addition, the IC50 values of RP444, RP445, and RP446 and the two isomeric forms of RP444 were determined using a platelet IIb/IIIa binding assay. Both isomeric forms of RP444 were found to have the same binding affinity (IC50 = 13 +/- 2 nM). Complexes [Tc-99(HYPY)(PPh3)(2)Cl-2] and [Tc-99(HYPY)(PPh3)(tricine)] were isolated from the reaction of HYPY with [n-Bu4N]TcOCl4-] in the presence of excess tricine and triphenylphospbine. [Tc-99(HYPY)(PPh3)(tricine)] serves as a model for ternary ligand [Tc-99m]HYNICtide complexes. Both complexes have been characterized by HPLC, spectroscopic (IR, NMR, and FAB-MS) methods, and elemental analysis. The HPLC concordance for complexes [Tc-99m(HYPY)(PPh3)(tricine)] and [Tc-99(HYPY)(PPh3)(tricine)] shows that the two complexes are identical. The NMR (H-1 and C-13) data suggests that the complex [Tc-99(HYPY)(PPh3)(tricine)] have an octahedral coordination geometry with a monodentate diazenido HYPY, a tetradentate tricine, and a monodentate triphenylphosphine coligand.
引用
收藏
页码:1326 / 1335
页数:10
相关论文
共 51 条
[31]  
LEVER SZ, 1994, J PHARM SCI, V84, P802
[32]  
Lister-James J, 1996, Q J Nucl Med, V40, P221
[33]  
Lister-James J, 1997, Q J Nucl Med, V41, P111
[34]   Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with Tc-99m using aminocarboxylates as coligands [J].
Liu, S ;
Edwards, DS ;
Looby, RJ ;
Harris, AR ;
Poirier, MJ ;
Barrett, JA ;
Heminway, SJ ;
Carroll, TR .
BIOCONJUGATE CHEMISTRY, 1996, 7 (01) :63-71
[35]   Labeling cyclic glycoprotein IIb/IIIa receptor antagonists with Tc-99m by the preformed chelate approach: Effects of chelators on properties of [Tc-99m]chelator-peptide conjugates [J].
Liu, S ;
Edwards, DS ;
Looby, RJ ;
Poirier, MJ ;
Rajopadhye, M ;
Bourque, JP ;
Carroll, TR .
BIOCONJUGATE CHEMISTRY, 1996, 7 (02) :196-202
[36]   A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands [J].
Liu, S ;
Edwards, DS ;
Harris, AR .
BIOCONJUGATE CHEMISTRY, 1998, 9 (05) :583-595
[37]   Tc-99m labeling of highly potent small peptides [J].
Liu, S ;
Edwards, DS ;
Barrett, JA .
BIOCONJUGATE CHEMISTRY, 1997, 8 (05) :621-636
[38]  
LIU S, 1995, TECHNETIUM RHENIUM C, V4, P383
[39]  
MAHMOOD A, 1995, TECHNETIUM RHENIUM C, V4, P211
[40]  
MARGUERIE GA, 1979, J BIOL CHEM, V254, P5357